Page last updated: 2024-09-03

kf 17837s and benserazide

kf 17837s has been researched along with benserazide in 1 studies

Compound Research Comparison

Studies
(kf 17837s)
Trials
(kf 17837s)
Recent Studies (post-2010)
(kf 17837s)
Studies
(benserazide)
Trials
(benserazide)
Recent Studies (post-2010) (benserazide)
39001,113162156

Protein Interaction Comparison

ProteinTaxonomykf 17837s (IC50)benserazide (IC50)
Genome polyproteinCoxsackievirus B3 (strain Nancy)2.4
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 20.14
Hexokinase-2Homo sapiens (human)5.52

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kanda, T; Nakamura, J; Shimada, J; Shiozaki, S; Suzuki, F1

Other Studies

1 other study(ies) available for kf 17837s and benserazide

ArticleYear
KF17837: a novel selective adenosine A2A receptor antagonist with anticataleptic activity.
    European journal of pharmacology, 1994, May-02, Volume: 256, Issue:3

    Topics: Adenosine; Administration, Oral; Animals; Antihypertensive Agents; Benserazide; Catalepsy; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Levodopa; Male; Mice; Phenethylamines; Purinergic Antagonists; Xanthines

1994